The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hyperthermic intraperitoneal chemotherapy following gastrectomy for the prevention of carcinomatosis in advanced gastric cancer: Nonrandomized phase II prospective trial.
Satoshi Murata
No relevant relationships to disclose
Hiroyuki Naito
No relevant relationships to disclose
Hiroshi Yamamoto
No relevant relationships to disclose
Tsuyoshi Yamaguchi
No relevant relationships to disclose
Tohru Miyake
No relevant relationships to disclose
Eiji Mekata
No relevant relationships to disclose
Tomoharu Shimizu
No relevant relationships to disclose
Hisanori Shiomi
No relevant relationships to disclose
Shigeyuki Naka
No relevant relationships to disclose
Hiromichi Sonoda
No relevant relationships to disclose
Tsuyoshi Mori
No relevant relationships to disclose
Hiroya Akabori
No relevant relationships to disclose
Yuki Kawai
No relevant relationships to disclose
Hirotomi Cho
No relevant relationships to disclose
Yoshihiro Kubota
No relevant relationships to disclose
Tomoko Umeda
No relevant relationships to disclose
Yoshihiro Endo
No relevant relationships to disclose
Hajime Abe
No relevant relationships to disclose
Yoshimasa Kurumi
No relevant relationships to disclose
Tohru Tani
No relevant relationships to disclose